Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 99

    Lupin inks commercial pact with Creso Pharma for cannaQIX

    Lupin inks commercial pact with Creso Pharma for cannaQIX

    Medical Dialogues Bureau27 Aug 2019 10:00 AM IST
    As per the agreement, Creso has given Pharma Dynamics sole distribution rights of its products across South Africa, Namibia, Botswana, Zimbabwe,...
    Boehringer Ingelheim to restructure executive board

    Boehringer Ingelheim to restructure executive board

    Medical Dialogues Bureau27 Aug 2019 9:30 AM IST
    Allan Hillgrove, head of pharmaceuticals and biopharma and a company veteran of 37 years, will retire at the end of the year and will be replaced by...
    JnJ directed to pay USD 572 million for opioid addiction crisis

    JnJ directed to pay USD 572 million for opioid addiction crisis

    Medical Dialogues Bureau27 Aug 2019 9:20 AM IST
    Norman (US): An Oklahoma judge on Monday found Johnson and Johnson(JnJ) and its subsidiaries helped fuel the state's opioid drug crisis and ordered...
    Amgen to pay hefty $13.4 billion for buying Celgene psoriasis drug Otezla

    Amgen to pay hefty $13.4 billion for buying Celgene psoriasis drug Otezla

    Medical Dialogues Bureau27 Aug 2019 9:15 AM IST
    Amgen, which announced the deal on Monday, is paying a hefty price for the drug, analysts and investors said. Still, Otezla will deliver growth for...
    CDSCO preparing list of dual-use APIs imported from unregistered firms

    CDSCO preparing list of dual-use APIs imported from unregistered firms

    Medical Dialogues Bureau26 Aug 2019 2:23 PM IST
    "The Central Drugs Standard Control Organisation (CDSCO), the Ministry of Health and the Department of Pharmaceuticals want to put a stop to the...
    Alkem Labs gets 4 USFDA observations for St Louis facility

    Alkem Labs gets 4 USFDA observations for St Louis facility

    Medical Dialogues Bureau26 Aug 2019 12:39 PM IST
    New Delhi: Drugmaker Alkem Laboratories (Alkem Labs) recently informed that the company has received four observations from the US health regulator...
    Lupin, Glenmark recall hypertension, fungal infection drugs from US market

    Lupin, Glenmark recall hypertension, fungal infection drugs from US market

    Medical Dialogues Bureau26 Aug 2019 9:45 AM IST
    New Delhi: Pharma major Glenmark is recalling over 31,000 tubes of anti-fungal Clotrimazole and Betamethasone Dipropionate cream from the US market,...
    Ghaziabad formulations facility gets 1 USFDA observation: Unichem Laboratories

    Ghaziabad formulations facility gets 1 USFDA observation: Unichem Laboratories

    Farhat Nasim26 Aug 2019 9:35 AM IST
    Unichem said it will provide the response and corrective action plan within the next 15 working days to address the USFDA observation for its...
    Opioid Lawsuit: Oklahoma judge to deliver judgment in first state case

    Opioid Lawsuit: Oklahoma judge to deliver judgment in first state case

    Medical Dialogues Bureau26 Aug 2019 9:00 AM IST
    Oklahoma Attorney General Mike Hunter has called consumer products giant JnJ, the last remaining defendant group in the case, a "kingpin" company that...
    CDSCO issues advisory on Labelling requirements for MTP combo kit of Misoprostol, Mifepristone tablet, Details

    CDSCO issues advisory on Labelling requirements for MTP combo kit of Misoprostol, Mifepristone tablet, Details

    Medical Dialogues Bureau25 Aug 2019 1:30 PM IST
    New Delhi: The apex drug regulatory body, Central Drugs Standard Control Organisation(CDSCO) has recently issued an advisory on labelling requirements...
    Novo Nordisk files suit against Mylan to block entry of generic Victoza drug in US

    Novo Nordisk files suit against Mylan to block entry of generic Victoza drug in US

    Medical Dialogues Bureau25 Aug 2019 9:50 AM IST
    “We can confirm that Novo Nordisk has filed a lawsuit against Mylan for patent infringement of Victoza,” the company said in an e-mail.COPENHAGEN:...
    GSK two-drug HIV injection shows promising result

    GSK two-drug HIV injection shows promising result

    Medical Dialogues Bureau25 Aug 2019 9:30 AM IST
    The long-acting needle-based combination of its drug cabotegravir and Janssen's treatment rilpivirine met its main goal in the study, which was...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok